Investment fund seeks legal action against DuPont over genetic technology
DuPont is being accused of civil fraud, negligent and intentional misrepresentation, waste of corporate assets and breach of fiduciary duties by an investment fund over the company's promotion of the GAT crop trait in which the plaintiffs labeled as a sham, Bloomberg reported.